Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, February 10, 2010, 8:30AM ET - U.S. Markets open in 1 hr.. Dow Up 1.52% Nasdaq  0.00%
Cytori Therapeutics, Inc. (CYTX)On Feb 9: 6.84   0.00 (0.00%)  
MORE ON CYTX
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, CA 92121
United States - Map
Phone: 858-458-0900
Fax: 858-458-0994
Web Site: http://www.cytoritx.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:88

BUSINESS SUMMARY 
Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. The company develops its product pipeline for the treatments of cardiovascular disease, spinal disc degeneration, gastrointestinal disorders, liver and renal disease, and pelvic health conditions. Its principal products include the Celution System family of products, which processes patients' cells at the bedside in real time. Each member of the Celution System family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzymes, and related instrumentation. The company also offers Celution 800/CRS System for the European cosmetic and reconstructive surgery market through a network of medical distributors; and the Celution 900/MB in Japan through its commercialization partner as part of the StemSource Cell Bank, which prepares cells for cryopreservation. Cytori Therapeutics is conducting two clinical trials on adipose-derived stem and regenerative cells processed with the Celution 600 System in patients suffering from chronic myocardial ischemia and in heart attack patients. In addition, it develops and sells thin film bioresorbable implants in Japan. Further, the company operates a tissue bank facility for the preservation of stem and regenerative cells extracted from adipose tissue. Additionally, it has a joint venture with Olympus Corporation to develop and manufacture second generation devices based on its Celution system. The company was founded in 1996 and is headquartered in San Diego, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Cytori Therapeutics, Inc.


    CORPORATE GOVERNANCE 
    Cytori Therapeutics, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Feb-10 is better than 32% of Russell 3000 companies and 37.6% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Christopher J. Calhoun , 44
    Co-Founder, Vice Chairman, Chief Exec. Officer, Sec. and Member of Exec. Committee
    $ 420.00K $ 471.00K
    Dr. Marc H. Hedrick M.D., 47
    Pres, Chief Scientific Officer, Medical Director
    $ 384.00K $ 0
    Mr. Mark E. Saad , 40
    Chief Financial Officer
    $ 350.00K $ 0
    Mr. Seijiro N. Shirahama , 56
    Pres of Asia Pacific
    $ 260.00K $ 0
    Mr. Bruce A. Reuter , 61
    Sr. VP of International Sales, Marketing & Distribution
    $ 254.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis